Vinker Shlomo, Shani Michal, Baevsky Tuvia, Elhayany Asher
Department of Family Medicine, Tel Aviv University, POB 14238, Ashdod 77042, Israel.
Am J Manag Care. 2008 Jun;14(6):388-92.
To describe adherence with statin treatment in a usual practice setting and to investigate potential determinants of better adherence.
Retrospective cohort study using administrative claims data.
Study patients were 47,680 individuals enrolled in the Central District of Clalit Health Services HMO in Israel who filled at least 1 prescription for statins between January 1, 1999, and December 31, 2006. Data were retrieved on patients' sex, year of birth and immigration, socioeconomic status, and whether they had diabetes mellitus, hypertension, and other cardiovascular diseases.
Mean age at the beginning of treatment was 61.3 +/- 11.8 years; 53.3% of the study patients were women. The proportion with at least 1 chronic disease before starting statins was 40.1%; and 38.9%, 21.8%, and 9.6% of the patients were continuously adherent after 1, 3, and 6 years, respectively. Risk of discontinuation was highest among new immigrants (hazard ratio [HR] = 1.20; 95% confidence interval [CI] = 1.14, 1.27). Adherence was higher in patients having a chronic disease before starting statins (HR = 0.88; 95% CI = 0.84, 0.94) or after starting statins (HR = 0.90; 95% CI = 0.86, 0.95). Patients age <50 or >79 years had lower adherence rates. Low socioeconomic state did not affect adherence.
Adherence with statin therapy was poor, though adherence rates were better in patients with accompanying chronic diseases. Of particular concern was the low level of adherence in new immigrants. Intervention programs are needed and should target all patient groups.
描述在常规医疗环境中他汀类药物治疗的依从性,并调查更好依从性的潜在决定因素。
使用行政索赔数据的回顾性队列研究。
研究患者为47680名在以色列克拉利特健康服务医疗保险组织中区登记的个体,他们在1999年1月1日至2006年12月31日期间至少开具了1份他汀类药物处方。收集了患者的性别、出生年份和移民年份、社会经济状况,以及他们是否患有糖尿病、高血压和其他心血管疾病的数据。
治疗开始时的平均年龄为61.3±11.8岁;53.3%的研究患者为女性。开始使用他汀类药物前至少患有一种慢性病的患者比例为40.1%;1年、3年和6年后持续依从的患者分别为38.9%、21.8%和9.6%。新移民停药风险最高(风险比[HR]=1.20;95%置信区间[CI]=1.14,1.27)。开始使用他汀类药物前患有慢性病的患者(HR=0.88;95%CI=0.84,0.94)或开始使用他汀类药物后(HR=0.90;95%CI=0.86,0.95)依从性更高。年龄<50岁或>79岁的患者依从率较低。低社会经济状态不影响依从性。
他汀类药物治疗的依从性较差,不过伴有慢性病的患者依从率较高。特别值得关注的是新移民的低依从性水平。需要干预项目,且应针对所有患者群体。